Clinicians at the MGH have been closely monitoring the spread of a new coronavirus – first detected in China last month. Erica Shenoy, MD, PhD, associate chief of the MGH Infection Control Unit, offers insight into what everyone should know about this virus.
Departments, Centers, & Programs:
Infectious Disease Associates
100 Blossom Street
Boston, MA 02114-2696
- MD, PhD, Harvard Medical School
- Residency, Massachusetts General Hospital
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Internal Medicine, American Board of Internal Medicine
- Infectious Disease, American Board of Internal Medicine
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
My research addresses the clinical, operational and economic impacts of competing Infection Control strategies for important nosocomial pathogens such as methicillin-resistant Staphylococcus aureus (MRSA). This involves hospital-based clinical studies, national survey-research, as well as “dry-bench” studies using computer-based simulation modeling. Our team collaborates with colleagues with expertise in computer science and articificial intelligence on risk prediction related to hospital acquired infections. I also collaborate with colleagues on research and implementation of antibiotic allergy evaluations.
- Jun | 12 | 2019
A research team from Mass General MIT, and the University of Michigan has developed a new method for predicting a patient's risk of contracting C. difficile.